Announce Date | 07/28/2025 |
EPS Normalized Actual | $0.87 (Beat by $0.02) |
EPS GAAP Actual | $0.87 (Beat by $0.02) |
Revenue Actual | $1.1315B |
Revenue Surprise | Beat by $1131.5M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 5.0496 | 7.16 | 4.96924 | 5.15224 | 1 |
Dec 2027 | 4.0033 | 9.03 | 3.89402 | 4.10568 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 0 | 1.1315B | 5.77% | 1131.5M |
FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 1.0041B | -15.18% | 1004.1M |
FQ4 2024 (Dec 2024) | 1.62 | 1.62 | 1.0972B | -6.68% | 1097.2M |
FQ3 2024 (Sep 2024) | 0.0867 | 0.0867 | 1.1157B | 15.08% | 1115.7M |
FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 1.0662B | 4.07% | 1066.2M |
FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 1.1565B | 13.01% | 1156.5M |
FQ4 2023 (Dec 2023) | 0.33 | 0.33 | 1.1705B | 16.82% | 1170.5M |
FQ3 2023 (Sep 2023) | 0 | 0 | 0.9475B | 4.45% | 947.5M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 1.25748 | -- | 1.23269 | 1.28227 | 2 |
FQ2 2028 (Jun 2028) | 1.17165 | -- | 1.14855 | 1.19475 | 2 |
FQ1 2028 (Mar 2028) | 1.11477 | -- | 1.0928 | 1.13674 | 2 |
FQ4 2027 (Oct 2027) | 0.9802 | -- | 0.9802 | 0.9802 | 1 |
FQ3 2027 (Jul 2027) | 0.8853 | -- | 0.8853 | 0.8853 | 1 |
FQ2 2027 (Jun 2027) | 0.8853 | -- | 0.86601 | 0.9041 | 1 |
FQ1 2027 (Mar 2027) | 0.8512 | -- | 0.83265 | 0.86928 | 1 |
FQ4 2026 (Oct 2026) | 0.939 | -- | 0.93034 | 0.94766 | 1 |
FQ3 2026 (Jul 2026) | 0.857 | -- | 0.8491 | 0.8649 | 1 |
FQ2 2026 (Jun 2026) | 0.86 | -- | 0.84607 | 0.87392 | 1 |
FQ1 2026 (Mar 2026) | 0.74 | 81.08 | 0.72801 | 0.75198 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 1.09B | -- | 1.07B | 1.1B | 1 |
FQ2 2028 (Jun 2028) | 1.08B | -- | 1.06B | 1.1B | 1 |
FQ1 2028 (Mar 2028) | 1.08B | -- | 1.07B | 1.1B | 1 |
FQ4 2027 (Oct 2027) | 1.03B | -- | 1.03B | 1.03B | 1 |
FQ3 2027 (Jul 2027) | 1.03B | -- | 1.03B | 1.03B | 1 |
FQ2 2027 (Jun 2027) | 1.03B | -- | 1.01B | 1.04B | 1 |
FQ1 2027 (Mar 2027) | 1.03B | -- | 1.02B | 1.05B | 1 |
FQ4 2026 (Oct 2026) | 0.97B | -- | 0.96B | 0.98B | 0 |
FQ3 2026 (Jul 2026) | 0.97B | -- | 0.96B | 0.97B | 0 |
FQ2 2026 (Jun 2026) | 0.97B | -17.25 | 0.95B | 0.98B | 1 |
FQ1 2026 (Mar 2026) | 0.97B | -3.52 | 0.96B | 0.98B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 100% | |
FQ4 2024 (Dec 2024) | 1.62 | 1.62 | 100% | |
FQ3 2024 (Sep 2024) | 0.0867 | 0.0867 | 100% | |
FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 100% | |
FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 100% | |
FQ4 2023 (Dec 2023) | 0.33 | 0.33 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $1.13B | $1131.5M | 100% |
FQ1 2025 (Mar 2025) | $0B | $1B | $1004.1M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.1B | $1097.2M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.12B | $1115.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.07B | $1066.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.16B | $1156.5M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.17B | $1170.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.95B | $947.5M | 100% |